Ian Bolland spoke to Dr Rutger Zietsma, CEO of Manus Neurodynamica about the company’s offering in neuromotor assessment devices. Share this:TwitterFacebookLike this:Like Loading... You May Also Like Healthcare Technology 25-05-2021 CVS Health launching new business arm to drive greater clinical trial participation Healthcare Technology 18-11-2020 Looking for feedback on a hospital pricing API Healthcare Technology 09-06-2021 Post-Pandemic, U.S. Healthcare is Entering a “Provide More Care For Less” Era – Pondering PwC’s 2022 Forecast Healthcare Technology 16-04-2021 Is a health informatics degree worth getting?